Company / Capital Returned to Shareholders
C4 Therapeutics, Inc. Capital Returned to Shareholders History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$193.0K
FY2025
5-year range
$110.0K / $193.0K
FY2023-FY2025
Trend
+75.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $110,000 to $193,000 over the past 2 years.
Based on SEC 10-K filings.
$193,000 in FY2025.
Improved from $110,000 to $193,000 over the past 2 years.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capital returned to shareholders increased 75.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $193.0K | +75.5% |
| FY2024 | $110.0K | +0.0% |
| FY2023 | $110.0K | - |
| FY2022 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026